Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

Total article views   Abstract views HTML views PDF downloads Totals
10,451 Dovepress* 10,451 0+ 2,948 10,451
Totals 10,451 0 2,948 10,451
*Since 12 April 2010
+Since July 2016

View citations on Google Scholar